BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Boston Scientific acquires Axonics in a $3.7B deal, enhancing its urology portfolio and expanding into sacral neuromodulation ...

Irvine, CA-headquartered Axonics’ products are available in more than 20 countries. The portfolio includes SNM therapy for overactive bladder (OAB) and incontinence, which is a minimally ...

"Over the last decade, it has been impressive to see the meaningful innovations Axonics has delivered for patients with overactive bladder and incontinence," said Meghan Scanlon, senior vice president ...

11/21 14:45 推送“及时、新鲜、有意思”的全球创新型企业新闻动态。 来自山东 波士顿科学公司近日宣布完成对Axonics, Inc.的收购。Axonics, Inc.是一家医疗技术公司，专注于开发和出售用以治疗膀胱和肠道功能障碍的新型产品。本次收购股权价值为37亿美元 ...

Co-founded company that makes sacral neuromodulation device to treat patients with overactive bladder conditions.   IN THE ...

马萨诸塞州马尔伯勒2024年11月19日/美通社/ -- 近日，波士顿科学公司（纽约证券交易所代码：BSX）宣布完成对Axonics, Inc ...